The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 16, Pages 8947
Publisher
MDPI AG
Online
2021-08-19
DOI
10.3390/ijms22168947
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
- (2021) Kate J. Dixon et al. Cancers
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
- (2020) Mangaiarkarasi Asokan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infection
- (2020) Niloufar Kavian et al. VACCINE
- When Therapeutic IgA Antibodies Might Come of Age
- (2020) Delphine Sterlin et al. PHARMACOLOGY
- Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
- (2020) Hilma J. van der Horst et al. Cancers
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies
- (2019) Mathilde Bas et al. JOURNAL OF IMMUNOLOGY
- M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model
- (2019) Sucharita Roy et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Human Fcγ receptors compete for TGN1412 binding that determines the antibody's effector function
- (2019) Simone Dudek et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
- (2019) Kevin O. Saunders Frontiers in Immunology
- iNK-CD64/16A cells: a promising approach for ADCC?
- (2019) Bruce Walcheck et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Impact of Fc N-glycan sialylation on IgG structure
- (2019) Zhongqi Zhang et al. mAbs
- Next-generation Fc receptor–targeting biologics for autoimmune diseases
- (2019) Adrian W. Zuercher et al. AUTOIMMUNITY REVIEWS
- Boosting therapeutic potency of antibodies by taming Fc domain functions
- (2019) Tae Hyun Kang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Optimal combination of beneficial mutations for improved ADCC effector function of aglycosylated antibodies
- (2019) Hyun Woung Yoon et al. MOLECULAR IMMUNOLOGY
- A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
- (2019) Emily J. Pomeroy et al. MOLECULAR THERAPY
- Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity
- (2019) Huang Zhu et al. BLOOD
- A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation
- (2018) Maaike Rijkers et al. HAEMATOLOGICA
- Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells
- (2018) Katja Srpan et al. JOURNAL OF CELL BIOLOGY
- A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation
- (2018) Maaike Rijkers et al. HAEMATOLOGICA
- Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics
- (2018) Chunpeng Yang et al. Frontiers in Immunology
- Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL)
- (2018) Shlomo Elias et al. OncoImmunology
- Crosstalk between Immune Cells and Mesenchymal Stromal Cells in a 3D Bioreactor System
- (2018) Martina Seifert et al. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
- Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
- (2018) Peter Ulrichts et al. JOURNAL OF CLINICAL INVESTIGATION
- Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies
- (2018) Karl R. VanDerMeid et al. Cancer Immunology Research
- Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice
- (2017) Megan Lo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab
- (2017) Sandra Prior et al. mAbs
- Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearance
- (2017) Migyeong Jo et al. mAbs
- Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
- (2017) Robert Marcus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular and functional analysis of monoclonal antibodies in support of biologics development
- (2017) Xin Wang et al. Protein & Cell
- Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
- (2017) Hongyan Liu et al. Frontiers in Immunology
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast Cancer
- (2017) Patrick G. Gavin et al. JAMA Oncology
- Atezolizumab: A PD-L1–Blocking Antibody for Bladder Cancer
- (2016) Brant A. Inman et al. CLINICAL CANCER RESEARCH
- Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa
- (2016) Alysia A. Ahmed et al. JOURNAL OF STRUCTURAL BIOLOGY
- Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies
- (2016) Marco Thomann et al. MOLECULAR IMMUNOLOGY
- An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
- (2016) Caroline Jochems et al. Oncotarget
- Human CD4+ T-Cells: A Role for Low-Affinity Fc Receptors
- (2016) Anil K. Chauhan Frontiers in Immunology
- Fc glycans of therapeutic antibodies as critical quality attributes
- (2015) Dietmar Reusch et al. GLYCOBIOLOGY
- Mouse and human FcR effector functions
- (2015) Pierre Bruhns et al. IMMUNOLOGICAL REVIEWS
- Fc receptor inside-out signaling and possible impact on antibody therapy
- (2015) Arianne M. Brandsma et al. IMMUNOLOGICAL REVIEWS
- Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
- (2015) Isaak Quast et al. JOURNAL OF CLINICAL INVESTIGATION
- Development and applications of AlphaScreen-based FcRn binding assay to characterize monoclonal antibodies
- (2015) Qiang Wu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Structural consequences of aglycosylated IgG Fc variants evolved for FcγRI binding
- (2015) Man-Seok Ju et al. MOLECULAR IMMUNOLOGY
- The Structural Role of Antibody N-Glycosylation in Receptor Interactions
- (2015) Ganesh P. Subedi et al. STRUCTURE
- Fc fusion as a platform technology: potential for modulating immunogenicity
- (2015) Ditza Levin et al. TRENDS IN BIOTECHNOLOGY
- A Monosaccharide Residue Is Sufficient to Maintain Mouse and Human IgG Subclass Activity and Directs IgG Effector Functions to Cellular Fc Receptors
- (2015) Daniela Kao et al. Cell Reports
- Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions
- (2015) D. J. DiLillo et al. Cancer Immunology Research
- Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody
- (2015) R. Stewart et al. Cancer Immunology Research
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
- (2015) Katayoun Rezvani et al. Frontiers in Immunology
- Identification of an ADAM17 Cleavage Region in Human CD16 (FcγRIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells
- (2015) Yawu Jing et al. PLoS One
- A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment
- (2014) Zahra Farajpour et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in 51Cr-release and CD107a assays
- (2014) Mariana M. Mata et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies — Impact of effector cells
- (2014) Shan Chung et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia
- (2014) Carolyn M Cheney et al. mAbs
- Development of a Cell-Based Assay Measuring the Activation of FcγRIIa for the Characterization of Therapeutic Monoclonal Antibodies
- (2014) Minoru Tada et al. PLoS One
- Human Cytomegalovirus Fcγ Binding Proteins gp34 and gp68 Antagonize Fcγ Receptors I, II and III
- (2014) Eugenia Corrales-Aguilar et al. PLoS Pathogens
- IgG Subclasses and Allotypes: From Structure to Effector Functions
- (2014) Gestur Vidarsson et al. Frontiers in Immunology
- The role of Fc gamma receptors in the activity of immunomodulatory antibodies for cancer
- (2014) Ross Stewart et al. Journal for ImmunoTherapy of Cancer
- LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity
- (2013) K. Krzewski et al. BLOOD
- Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
- (2013) A. Wiernik et al. CLINICAL CANCER RESEARCH
- Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics
- (2013) Abhishek Mathur et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Cutting Edge: Expression of Fc RIIB Tempers Memory CD8 T Cell Function In Vivo
- (2013) G. R. Starbeck-Miller et al. JOURNAL OF IMMUNOLOGY
- Impact of Immune Complex Size and Glycosylation on IgG Binding to Human Fc Rs
- (2013) A. Lux et al. JOURNAL OF IMMUNOLOGY
- Antibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletion
- (2013) M Le Garff-Tavernier et al. LEUKEMIA
- Characterization of monoclonal antibody size variants containing extra light chains
- (2013) Connie Lu et al. mAbs
- Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
- (2013) Maya K Leabman et al. mAbs
- Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties
- (2013) Christian Klein et al. mAbs
- An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations
- (2013) Omid Vafa et al. METHODS
- Priming after a Fractional Dose of Inactivated Poliovirus Vaccine
- (2013) Sonia Resik et al. NEW ENGLAND JOURNAL OF MEDICINE
- General mechanism for modulating immunoglobulin effector function
- (2013) P. Sondermann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isotype and glycoform selection for antibody therapeutics
- (2012) Roy Jefferis ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The State of the Art in the Development of Biosimilars
- (2012) Mark McCamish et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Fc-fusion proteins: new developments and future perspectives
- (2012) Daniel M. Czajkowsky et al. EMBO Molecular Medicine
- Development of an ELISA based bridging assay as a surrogate measure of ADCC
- (2012) Aaron S. Miller et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors
- (2012) Eugenia Corrales-Aguilar et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Antibody C Region Influences TGN1412-like Functional Activity In Vitro
- (2012) C. Ball et al. JOURNAL OF IMMUNOLOGY
- A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
- (2012) Gregory L. Moore et al. mAbs
- Marketing approval of mogamulizumab
- (2012) Alain Beck et al. mAbs
- Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay
- (2012) Bhavin S. Parekh et al. mAbs
- Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
- (2012) M. K. Gleason et al. MOLECULAR CANCER THERAPEUTICS
- Mouse model recapitulating human Fc receptor structural and functional diversity
- (2012) P. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies
- (2011) W. Alduaij et al. BLOOD
- Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies
- (2011) G. Niederfellner et al. BLOOD
- Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets
- (2011) Peter J Bugelski et al. BRITISH JOURNAL OF PHARMACOLOGY
- Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies
- (2011) Alfred Schnueriger et al. MOLECULAR IMMUNOLOGY
- Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose
- (2011) C. Ferrara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays
- (2011) Zachary B. Davis et al. Jove-Journal of Visualized Experiments
- Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
- (2010) E. Mossner et al. BLOOD
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Teplizumab therapy for type 1 diabetes
- (2010) Umesh B Masharani et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Acute infusion reactions induced by monoclonal antibody therapy
- (2010) Enrico Maggi et al. Expert Review of Clinical Immunology
- Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma
- (2010) Kazuhito Yamamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
- (2010) Margaret E. Ackerman et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
- (2010) Takuo Suzuki et al. JOURNAL OF IMMUNOLOGY
- Fc-Glycosylation Influences Fc Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12
- (2010) D. N. Forthal et al. JOURNAL OF IMMUNOLOGY
- IgG2m4, an engineered antibody isotype with reduced Fc function
- (2010) Zhiqiang An et al. mAbs
- Production of therapeutic antibodies with controlled fucosylation
- (2010) Naoko Yamane-Ohnuki et al. mAbs
- Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodies
- (2010) Carmel M. Lynch et al. mAbs
- Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
- (2010) Frank R. Brennan et al. mAbs
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- Optimization of Fc-mediated effector functions of monoclonal antibodies
- (2009) William R Strohl CURRENT OPINION IN BIOTECHNOLOGY
- Alternative Strategies for Toxicity Testing of Species-Specific Biopharmaceuticals
- (2009) Jeanine L. Bussiere et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- Structural characterization of a human Fc fragment engineered for extended serum half-life
- (2009) Vaheh Oganesyan et al. MOLECULAR IMMUNOLOGY
- Glycosylation as a strategy to improve antibody-based therapeutics
- (2009) Roy Jefferis NATURE REVIEWS DRUG DISCOVERY
- Aglycosylated IgG variants expressed in bacteria that selectively bind Fc RI potentiate tumor cell killing by monocyte-dendritic cells
- (2009) S. T. Jung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
- (2009) Royston Jefferis TRENDS IN PHARMACOLOGICAL SCIENCES
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16
- (2008) Christophe de Romeuf et al. BRITISH JOURNAL OF HAEMATOLOGY
- Engineered Antibodies of IgG1/IgG3 Mixed Isotype with Enhanced Cytotoxic Activities
- (2008) A. Natsume et al. CANCER RESEARCH
- Fc RIIIa Expression Is Not Increased on Natural Killer Cells Expressing the Fc RIIIa-158V Allotype
- (2008) N. Congy-Jolivet et al. CANCER RESEARCH
- Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
- (2008) Alain Beck et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Monoclonal Antibody First Dose Cytokine Release Syndromes–Mechanisms and Prediction
- (2008) Mark Wing Journal of Immunotoxicology
- Structural characterization of a mutated, ADCC-enhanced human Fc fragment
- (2008) Vaheh Oganesyan et al. MOLECULAR IMMUNOLOGY
- Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
- (2008) Zoe Waibler et al. PLoS One
- Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors
- (2008) S. L. Sazinsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
- (2008) R. M. Anthony et al. SCIENCE
- Factors determining antibody distribution in tumors
- (2008) G THURBER et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Glycosylation of Recombinant Antibody Therapeutics
- (2005) Royston Jefferis BIOTECHNOLOGY PROGRESS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now